Elekta AB (Elekta AB) FCF Margin % : 13.93% (As of Jan. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Elekta AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Elekta AB's Free Cash Flow for the three months ended in Jan. 2024 was $61 Mil. Elekta AB's Revenue for the three months ended in Jan. 2024 was $438 Mil. Therefore, Elekta AB's FCF Margin % for the quarter that ended in Jan. 2024 was 13.93%.

As of today, Elekta AB's current FCF Yield % is 5.31%.

The historical rank and industry rank for Elekta AB's FCF Margin % or its related term are showing as below:

EKTAY' s FCF Margin % Range Over the Past 10 Years
Min: 1.73 Med: 6.12 Max: 13.39
Current: 8.5

During the past 13 years, the highest FCF Margin % of Elekta AB was 13.39%. The lowest was 1.73%. And the median was 6.12%.

EKTAY's FCF Margin % is ranked better than
76.97% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -7.12 vs EKTAY: 8.50

Elekta AB FCF Margin % Historical Data

The historical data trend for Elekta AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB FCF Margin % Chart

Elekta AB Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

FCF Margin %

Get a 7-Day Free Trial

7.10

1.73

12.40

3.09

2.37

Elekta AB Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
FCF Margin %	Get a 7-Day Free Trial															-3.78	30.70	-23.43	4.46	13.93

Competitive Comparison of Elekta AB's FCF Margin %

For the Medical Instruments & Supplies subindustry, Elekta AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elekta AB's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Elekta AB's FCF Margin % falls into.

Elekta AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Elekta AB's FCF Margin for the fiscal year that ended in Apr. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Apr. 2023 )	/	Revenue (A: Apr. 2023 )
	=	38.654	/	1630.107
	=	2.37 %

Elekta AB's FCF Margin for the quarter that ended in Jan. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jan. 2024 )	/	Revenue (Q: Jan. 2024 )
	=	61.008	/	437.964
	=	13.93 %

Elekta AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Elekta AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Elekta AB (Elekta AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OTCPK:EKTAY) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

EKTAF:USA EKTA B:Sweden EKTAB:Mexico EKTABs:UK 0O5H:UK EJXB:Germany

Address

Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93

Website

https://www.elekta.com

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.